Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 1,441 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Measurement Clear all

Conditions: Healthy, Obesity
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Algorithm Verification
Interventions: There is no intervention; Other
Lead sponsor: Intelomed, Inc.; Industry
Eligibility: 21 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Cranberry Township, Pennsylvania

Conditions: Epilepsies, Partial
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy
Interventions: Methylphenidate, Triazolam, Project: EVO, Placebo; Drug · Other
Lead sponsor: Akili Interactive Labs, Inc.; Industry
Eligibility: 40 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Alcohol Drinking
Interventions: Smartwatch to measure Blood Alcohol Level (BAL); Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 21 Years to 55 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetic Neuropathy, Chemotherapy Induced Neuropathy, HIV Neuropathy, Trauma Induced Neuropathy
Interventions: Neuron012703 (Medical Food); Drug
Lead sponsor: Targeted Medical Pharma; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Shoulder Impingement Syndrome
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Complication of Surgical Procedure
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 50 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Colonic Polyp
Interventions: Visual estimation of polyp size, Napoleon measurement of polyp size; Other · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 45 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Brooklyn, New York • New York, New York

Conditions: HIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis
Interventions: Diagnostic Test, HIV Anti-retroviral Background Therapy; Diagnostic Test · Drug
Lead sponsor: Theratechnologies; Industry
Eligibility: 18 Years and older
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 8
States / cities: Los Angeles, California • Fort Lauderdale, Florida • Miami Beach, Florida + 4 more

Conditions: Heart Failure，Congestive
Interventions: Non-invasive central venous pressure; Device
Lead sponsor: Nihon Kohden; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Hypotension and Shock
Interventions: Lower body negative pressure; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
Interventions: Vibration-controlled transient elastography; Device
Lead sponsor: William Jennings Bryan Dorn VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Chronic Pain, Osteoarthritis, Knee
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Retinal Detachment, Rhegmatogenous Retinal Detachment
Interventions: Lamivudine 300 MG, Placebo; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hot Flashes
Interventions: physiologic testing; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy Volunteers
Interventions: tanezumab; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Cypress, California

Conditions: Parkinson Disease, Weight-Lifting Exercise Program
Interventions: Strength Training, Power Training; Other
Lead sponsor: University of Miami; Other
Eligibility: 40 Years to 89 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Corneal Endothelial Cell Loss
Interventions: Topcon Specular Microscope SP-1P, Konan Specular Microscope CELLCHEK XL; Device
Lead sponsor: Topcon Medical Systems, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Pain
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Thermometry
Interventions: Infrared Thermography; Diagnostic Test
Lead sponsor: Thermal Diagnostics LLC; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Northfield, Minnesota

Conditions: NYHA Class III Heart Failure
Interventions: SOZO; Device
Lead sponsor: ImpediMed Limited; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Rochester, Minnesota • Lancaster, Pennsylvania

Conditions: Laryngotracheal Stenosis
Interventions: Measure Airway Resistance Across Stenosis; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Waste Management, Recycling, Climate, Nutrition Sciences
Interventions: Survey Curbside; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans

mCVI Confirmatory Clinical Study: Algorithm Verification With Healthy Volunteers

Brain P-gp and Inflammation in People With Epilepsy

Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents

Calibration Study of a Blood Alcohol Level Smart Watch

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

ClinicCompanion. Compared to the Use of a Goniometer

Measurement of Feeding Experience for Infants With Non-Oral Feedings

Use of the Napoleon to Improve Polyp Measurement in Gastroenterology Fellows

The Visceral Adiposity Measurement and Observation Study

Comparison of Non-invasive Vs. Invasive Hemodynamic Measurements

Measurement of Hemodynamic Responses to Lower Body Negative Pressure

Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease

Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity

Lamivudine and Plasma Markers of Inflammation in Retinal Detachment

Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Training and Parkinson's

Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements

Evaluation of Pain Measurement Device

Principles and Test Methods of Non-contact Body Thermometry

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

Assessment of Primary Oxygenation and Airflow Measurement for Endoscopic Laryngeal Surgery

Food Survey, Curbside, Remote APPs SC